临床儿科杂志 ›› 2023, Vol. 41 ›› Issue (7): 556-560.doi: 10.12372/jcp.2023.23e0465

• 继续医学教育 • 上一篇    

母乳低聚糖在婴幼儿临床中的应用及在中国的展望

姜璐, 蔡威()   

  1. 上海交通大学医学院附属新华医院(上海 200092)
  • 收稿日期:2023-05-29 出版日期:2023-07-15 发布日期:2023-07-05
  • 通讯作者: 蔡威 E-mail:caiw1978@163.com

Clinical applications of human milk oligosaccharides in infants

JIANG Lu, CAI Wei()   

  1. Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
  • Received:2023-05-29 Online:2023-07-15 Published:2023-07-05
  • Contact: CAI Wei E-mail:caiw1978@163.com

摘要:

母乳低聚糖(HMOs)是母乳中特有的、含量丰富的复合碳水化合物,作为母乳中含量第三的成分逐渐受到国内外学者关注。随着分析技术和多组学的快速发展,HMOs的研究已经取得了长足发展,并在过去几年取得较大突破。然而,我们仍处于揭示HMOs作用及机制的初级阶段,现有的结论主要来自于国外的临床研究,且仍需要进一步通过高质量的随机临床试验进行验证,并考虑其在不同疾病、环境和人群中的有效性。文章主要针对近年来HMOs对婴幼儿肠道菌群发育、肠道健康、免疫系统发育和脑部发育在临床中的应用作一简述,并对未来HMOs在中国婴幼儿中的应用前景进行探讨。

关键词: 母乳低聚糖, 肠道健康, 免疫系统发育

Abstract:

Human milk oligosaccharides (HMOs) are unique and abundant complex carbohydrates in breast milk. As the third most abundant component in breast milk, they have gradually received attention from scholars both domestically and internationally. With the rapid development of analytical techniques and multiomics, the research field of HMOs has made great progress and made great breakthroughs in the past few years. However, we are still in the initial stage of revealing the role and mechanisms of HMOs. However, the conclusions are mainly from foreign clinical studies, and need to be further verified by high-quality randomized clinical trials. In addition, we need to consider its effectiveness in different diseases, environment, and populations. Here, we summarize the roles of HMOs in regulating gut microbiome development, intestinal health, immune system development, and brain development in infants. Additionally, we explore the potential future applications of HMOs in infants in China.

Key words: human milk oligosaccharides, intestinal health, immune system development